Quantcast Mike Terretti's Daily Pharma News
Mike Terretti's Daily Pharma News By Mike Terretti 919-781-0400x112
Mike Terretti’s focus is the Pharmaceutical and Biotechnology Industries in Executive Recruitment. THe following information drives all the growth and opportunity in our market.
Mike Terretti's Daily Pharma News >> BIOTECH November 27, 2009 members login here
Public San Francisco -Global Clinical Research -Oncology 
My Public San Francisco area client is focused on the development and commercialization of novel therapeutics for oncology.
This position in the overall management of the clinical project team and with the development of clinical plans and implementation of clinical trials.
Executive Director, Global Clinical Research and Development-Oncology

Essential functions include, but are not limited to the following:
• Oversee... Read More    Add Comment

More
>>  BIOTECH
Sinovac Biotech signs new joint venture agreement - Zibb.com
Zibb - 5 Hours ago
Company: Sinovac Biotech Ltd (SVA) Sinovac Biotech, a developer and provider of vaccines, has signed a joint venture or JV agreement to establish Sinovac Dalian Vaccine Technology. The joint venture (JV)
Sinovac Biotech signs new joint venture agreement Individual.com
Mulk Holdings signs joint venture to manufacture aluminium panels Zawya.com
all 2 news articles >>      Add Comment

Is Gene-Therapy Medical Treatment Ready for Prime Time?
Time - 8 Hours ago
At first it sounded like science fiction, curing genetic diseases by giving people new genes. Then it seemed like simple fiction: while theoretically possible, gene therapy appeared unlikely to become
Is Gene Therapy Finally Ready for Prime Time? Time
all 1 news articles >>      Add Comment

Biotech Bargains for Your Portfolio
Motley Fool - 4 Hours ago
Everyone is looking for bargains this time of year. That includes pharmaceutical giants looking to pick up some biotechs on the discount rack, and investors trying to get there first. The easiest way
     Add Comment

4-Star Stocks Poised to Pop: Wal-Mart
Motley Fool - 5 Hours ago
Based on the aggregated intelligence of 145,000-plus investors participating in , the Fool's free investing community, retail behemoth Wal-Mart Stores (NYSE: WMT) With that in mind, let's take a closer
5-Star Stocks Poised to Pop: Exelon Motley Fool via MSN Money
4-Star Stocks Poised to Pop: Sequenom The Money Times
all 6 news articles >>      Add Comment

Incyte signs license agreement with Novartis for INCB18424 and INCB28060
TradingMarkets - 110 Minutes ago
Look up the PowerRating of INCY,NVS and see how it has performed over the past week as well as the current proprietary PowerRating. Nov 27, 2009 (Datamonitor Financial Deals Tracker via COMTEX) -- NVS
Incyte enters collaboration & license pact with Novartis for 2 haematology-oncology PharmaBiz
Incyte signs collaboration and licensing agreement with Novartis ... Zibb
all 3 news articles >>      Add Comment

FSA to canvass pubic opinion on GM foods
Farmers Guardian - 7 Hours ago
THE Food Standards Agency (FSA) is launching a mass public consultation to engage consumers on the controversial debate over GM foods. At the request of Government the FSA has set up the GM dialogue steering
     Add Comment

Conference calls for strategy to guide biotech industry
MENAFN - 11 Hours ago
MENAFN - Jordan Times - 27/11/2009 (MENAFN - Jordan Times) Experts have called for policies and strategies to guide the biotechnology industry and stem cell research in Jordan. At the conclusion of the
     Add Comment

Postdoctoral Research in Functional Genomics
Nature - 13 Hours ago
Homepage > Job search > Job description : Boston, MA Employer: Location: Boston, MA Posted: November 23, 2009 Expires: January 22, 2010 Jobs by tag(s): biostatistics ma Harvard Boston Requisition number:
     Add Comment

Sinovac forms JV to expand human vaccine capabilities
Bio Spectrum Asia - 13 Hours ago
Chinese vaccine major Sinovac Biotech has established a joint venture (JV), Sinovac (Dalian) Vaccine Technology Limited, to expand its human-use vaccine development and manufacturing capabilities. Sinovac
Sinovac forms joint venture to expand vaccine development and manufacturing capabilities Manufacturing Chemist
Barclays Capital forms joint venture with Goff Capital Individual.com
all 13 news articles >>      Add Comment

Human Genome Sciences submits Zalbin BLA to US FDA to treat chronic hepatitis C
PharmaBiz - 13 Hours ago
Human Genome Sciences, Inc has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for Zalbin (albinterferon alfa-2b) for the treatment of chronic hepatitis C.
Human Genome Sciences submitted application for new drug Zalbin Charlotte Business Journal
Human Genome Sciences Submits Biologics License Application to FDA for ZALBINââ??¢ Genetic Engineering News
all 15 news articles >>      Add Comment

Bayer CropScience signs Agreement with GVK Biosciences on early-stage research projects
Chemie.de - 14 Hours ago
ayer CropScience and GVK Biosciences Private Limited (GVK BIO), Hyderabad, India, have entered into a research cooperation in the area of early discovery chemistry. The objective is to speed up the search
GVK Bio inks pact with Bayer for early-stage research projects PharmaBiz
Bayer CropScience in Research Cooperation with GVK Biosciences Chemical Week
all 6 news articles >>      Add Comment

Monsanto Fund Helping Keep Kids Safe by Sponsoring FS4JK
USAgNet - 15 Hours ago
The Monsanto Fund, the philanthropic arm of Monsanto Company, recently made the safety of our youth a priority by sponsoring Farm Safety 4 Just Kids (FS4JK), Urbandale, Iowa, with a $14,000 grant. Farm
     Add Comment

Chugai Revises Corporate Advertisement for First Time in Four Years
CHUGAI PHARMACEUTICAL - 17 Hours ago
Spreading the message of Chugai's corporate mission of offering innovative drugs for cancer, rheumatoid arthritis, renal anemia and hepatitis C November 25, 2009 (Tokyo) - Chugai Pharmaceutical Co., Ltd.
     Add Comment

Why GMOs Are Bad
Institute of Sciences in Society - 18 Hours ago
Science of the Organism & Sustainable Systems Invited lecture, The Alternative View, 13-15 November, Grand Thistle Hotel, Bristol, UK Monsanto has surreptitiously withdrawn its high lysine GM maize
     Add Comment

BiomedReports: News and FDA Updates for GLG (NASDAQ:GLGL), Human Genome Sciences
TMC Net - 18 Hours ago
(M2 PRESSWIRE via COMTEX) -- BioMedReports. Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community of highly informed investors
     Add Comment

Bayer CropScience gains approval for field vegetable fungicide Rudis on Brussels
Horticulture Week - 4 Hours ago
Brassica growers can now use the field vegetable fungicide Rudis on Brussels sprouts crops as Bayer CropScience has gained approval for its use.
Bayer CropScience signs research agreement with GVK Biosciences Individual.com
Bayer CropScience to speed crop protection R&D in agreement with GVK Biosciences AgProfessional
all 5 news articles >>      Add Comment

UK: New Study Shows Consumers Want More Information GM Foods (Subscribers Only Content)
Kamcity - 93 Minutes ago
Please login to read the following story - UK: New Study Shows Consumers Want More Information GM Foods
UK: New Study Shows Consumers Want More Information GM Foods (Subscribers Only Kamcity
FDA Consumer Health Information: Food Safety Tips for Healthy Holidays Ulitzer
all 3 news articles >>      Add Comment

Plant scientists build a 'Sears catalog' for corn genome
Taiwan News Online - 5 Hours ago
Plant scientists announced last week they have built the foundation for a complete catalog for corn genes, with far-reaching implications for humanity's food supply. Researchers have
     Add Comment

FMC Corporation Executives to Address Investors at December Conferences
ThomasNet - 5 Hours ago
Company web site More news from this companyNewsletters Your Gateway to a Fast Changing World Product News Alerts Receive similar stories and other customized news to keep you in the know on the products
Monsanto executives to address investors at December events Your Industry News
QLogic Executives to Present at December Investor Conferences QLogic
all 2 news articles >>      Add Comment

Human Genome Sciences Inc announces submisssion of BLA for ZALBIN for hepatitis
Individual.com - 6 Hours ago
Medicine supplier Human Genome Sciences Inc (Nasdaq:HGSI) said on Wednesday that the company has submitted a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) for ZALBIN
     Add Comment

Gilead Sciences and GlaxoSmithKline sign agreement to commercialize Viread(R)
Individual.com - 6 Hours ago
Gilead Sciences, Inc. and GlaxoSmithKline plc (GSK) have signed a licensing agreement to commercialize Viread(R) (tenofovir disoproxil fumarate) for the treatment of chronic hepatitis B (HBV) infection
Gilead, GSK Announce Viread Agreement In Asia (GILD,GSK) Quote.com Singapore
Gilead Sciences and GlaxoSmithKline sign agreement to commerciali... Zibb
all 12 news articles >>      Add Comment

Swedish Biovitrum expands Kineret licence from Amgen
ADP News - 9 Hours ago
- Swedish biotech company Biovitrum (STO:BVT) said today that it agreed with US sector major Amgen Inc (NASDAQ:AMGN) to expand Biovitrum's licence to the rheumatoid arthritis drug Kineret to include certain
Biovitrum Expands Kineret(R) License to Include Certain Orphan Indications Individual.com
Biovitrum expands Kineret license to include certain orphan indications Therapeutics Daily
all 4 news articles >>      Add Comment

Sanofi Aventis : Sanofi-aventis confirme son...
Investegate - 7 Hours ago
PR Newswire/Les Echos/ Communiqué de presse Sanofi-aventis Sanofi-aventis confirme son intention de renforcer sa présence en Russie grâce au Projet " Pharmpolis " - Signature au Séminaire intergouvernemental
Sanofi-Aventis To Participate In Russian Project FOXBusiness.com
Sanofi Aventis : Sanofi-aventis confirms its... Investegate
all 4 news articles >>      Add Comment

Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
Poten & Partners - 9 Hours ago
- (NewsRx.com) -- Kun Run Biotechnology, Inc. (the 'Company' or 'Kun Run') (BULLETIN BOARD: KURU) , a leading bio-pharmaceutical company in China that focuses on manufacturing and sales of peptides and
     Add Comment

Gyros, DI Biotech sign distribution agreement for the Korean market
Bio Spectrum Asia - 11 Hours ago
Gyros, a top developer of automated micro-immunoassays for therapeutic protein development has signed a distribution agreement with DI Biotech, the leading supplier to the Korean life-science market.
A-DATA Announces Signing of Distribution Agreement with Synnex GISUser
all 1 news articles >>      Add Comment

Already a member? Sign in
Email Address:
Password:
Forget your password?

Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms of Use   |   Privacy Policy   |   Need Help?   |   Site Map
Copyright ©2009 Congoo.com. All Rights Reserved.